Adriana Zardini Buzatto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adriana Zardini Buzatto has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Liang Li
The Metabolomics Innovation Centre, Department of Chemistry, University of Alberta, Edmonton, AB T6G 2G2, Canada
13 shared publications - Ana Valéria Colnaghi Simionato
Laboratory of Analysis of Biomolecules Tiselius, Institute of Chemistry, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
4 shared publications - Anas M. Abdel Rahman
Metabolomics Section, Precision Medicine Laboratory Department, Genomics Medicine Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia
4 shared publications - Shuang Zhao
The Metabolomics Innovation Centre (TMIC), University of Alberta, Edmonton, AB T6G 2G2, Canada
3 shared publications - Timothy R. H. Regnault
Western University
3 shared publications - Zachary J. W. Easton
Department of Physiology and Pharmacology, Western University, Medical Sciences Building Room 216, London, ON N6A 5C1, Canada
3 shared publications
Latest Publications
- 13 October 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (11) , 6206-6226
Metabolic Quenching and Growth Medium Shape Strain-Level Interpretation in Untargeted Escherichia coli Lipidomics
Untargeted bacterial lipidomics is increasingly used to investigate membrane adaptation, host–pathogen interactions, antimicrobial stress responses, and microbial phenotypic variation, but the measured lipidome depends strongly on experimental design. Preanalytical variables can alter lipid recovery, introduce handling-derived artifacts, and change biological interpretation. Here, we evaluated how methanol-based quenching, growth medium, and strain background affect LC-MS/MS untargeted Escherichia coli lipidomics. Three strains, ATCC 25922, O127:H6, and O157:H7, were grown in chemically defined M9 medium or tryptic soy broth to late stationary phase. Lipids were extracted from biomass-normalized bacterial pellets using dichloromethane and analyzed by reversed-phase LC–MS/MS. Methanol-based quenching did not improve reproducibility and altered the abundance of metabolically active lipid species, such as lysophospholipids and quinones. Growth medium had greater effects than strain identity, altering phospholipid balance and the detectability of strain-specific lipid phenotypes. Under controlled handling and culture conditions, pathogenic strains exhibited distinct lipidomic profiles, including increased cardiolipins and phosphatidic acids, elevated lysophospholipid ratios, and reduced diacylglycerol levels. These results define practical constraints for bacterial lipidomics workflows and show that strain-level lipid phenotypes require control of quenching strategy and growth medium.
- 13 October 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (11) , 6206-6226
Metabolic Quenching and Growth Medium Shape Strain-Level Interpretation in Untargeted Escherichia coli Lipidomics
Untargeted bacterial lipidomics is increasingly used to investigate membrane adaptation, host–pathogen interactions, antimicrobial stress responses, and microbial phenotypic variation, but the measured lipidome depends strongly on experimental design. Preanalytical variables can alter lipid recovery, introduce handling-derived artifacts, and change biological interpretation. Here, we evaluated how methanol-based quenching, growth medium, and strain background affect LC-MS/MS untargeted Escherichia coli lipidomics. Three strains, ATCC 25922, O127:H6, and O157:H7, were grown in chemically defined M9 medium or tryptic soy broth to late stationary phase. Lipids were extracted from biomass-normalized bacterial pellets using dichloromethane and analyzed by reversed-phase LC–MS/MS. Methanol-based quenching did not improve reproducibility and altered the abundance of metabolically active lipid species, such as lysophospholipids and quinones. Growth medium had greater effects than strain identity, altering phospholipid balance and the detectability of strain-specific lipid phenotypes. Under controlled handling and culture conditions, pathogenic strains exhibited distinct lipidomic profiles, including increased cardiolipins and phosphatidic acids, elevated lysophospholipid ratios, and reduced diacylglycerol levels. These results define practical constraints for bacterial lipidomics workflows and show that strain-level lipid phenotypes require control of quenching strategy and growth medium.
- 23 September 2026
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1425
Enhancing untargeted lipidomics using offline two-dimensional LC–MS and systematic evaluation of data processing tools
- 23 September 2026
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1425
Enhancing untargeted lipidomics using offline two-dimensional LC–MS and systematic evaluation of data processing tools
- Open Access
- 1 June 2026
- Published by Elsevier in STAR Protocols
- Vol. 7 (2) , 104607
Protocol for untargeted lipidomics of human serum using LC-TIMS-PASEF
- 1 June 2026
- Published by Elsevier in STAR Protocols
- Vol. 7 (2) , 104607
Open AccessProtocol for untargeted lipidomics of human serum using LC-TIMS-PASEF
- Open Access
- 6 March 2026
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 153, 110337
Prebiotics partially protect offspring from maternal antibiotic-induced obesity risk by altering maternal milk microbiota and gut colonization in Sprague-Dawley rats
- 6 March 2026
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 153, 110337
Open AccessPrebiotics partially protect offspring from maternal antibiotic-induced obesity risk by altering maternal milk microbiota and gut colonization in Sprague-Dawley rats
- Open Access
- 9 January 2026
- Published by Elsevier in BBA Advances
- Vol. 9
Lipidomic profiling of Arabidopsis chloroplast protein phosphatase SLP1 mutants reveals altered diurnal lipid remodeling
- 9 January 2026
- Published by Elsevier in BBA Advances
- Vol. 9
Open AccessLipidomic profiling of Arabidopsis chloroplast protein phosphatase SLP1 mutants reveals altered diurnal lipid remodeling
- 30 September 2025
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1378, 344652
Development of a robust sulfo-phospho-vanillin assay for sample normalization in LC-MS-based lipidomics
- 30 September 2025
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1378, 344652
Development of a robust sulfo-phospho-vanillin assay for sample normalization in LC-MS-based lipidomics
- Open Access
- 11 March 2025
- Published by MDPI AG in Metabolites
- Vol. 15 (3) , 193
The Lipid Composition of the Exo-Metabolome from Haemonchus contortus
Background/Objectives: Metabolomic studies of different parasite-derived biomolecules, such as lipids, are needed to broaden the discovery of novel targets and overcome anthelmintic resistance. Lipids are involved in diverse functions in biological systems, including parasitic helminths, but little is known about their role in the biology of these organisms and their impact on host–parasite interactions. This study aimed to characterize the lipid profile secreted by Haemonchus contortus, the major parasitic nematodes of farm ruminants. Methods: H. contortus adult worms were recovered from infected sheep and cultured ex vivo. Parasite medium was collected at different time points and samples were subjected to an untargeted global lipidomic analysis. Lipids were extracted and subjected to Liquid Chromatography–Mass Spectrometry (LC-MS/MS). Annotated lipids were normalized and subjected to statistical analysis. Lipid clusters’ fold change (FC) and individual lipid features were compared at different time points. Lipids were also analyzed by structural composition and saturation bonding. Results: A total of 1057 H. contortus lipid features were annotated, including glycerophospholipids, fatty acyls, sphingolipids, glycerolipids, and sterols. Most of these compounds were unsaturated lipids. We found significant FC differences in the lipid profile in a time-dependent manner. Conclusions: We predict that many lipids found in our study act as signaling molecules for nematodes’ physiological functions, such as adaptation to nutrient changes, life span and mating, and as modulators on the host immune responses.
- 11 March 2025
- Published by MDPI AG in Metabolites
- Vol. 15 (3) , 193
Open AccessThe Lipid Composition of the Exo-Metabolome from Haemonchus contortus
Background/Objectives: Metabolomic studies of different parasite-derived biomolecules, such as lipids, are needed to broaden the discovery of novel targets and overcome anthelmintic resistance. Lipids are involved in diverse functions in biological systems, including parasitic helminths, but little is known about their role in the biology of these organisms and their impact on host–parasite interactions. This study aimed to characterize the lipid profile secreted by Haemonchus contortus, the major parasitic nematodes of farm ruminants. Methods: H. contortus adult worms were recovered from infected sheep and cultured ex vivo. Parasite medium was collected at different time points and samples were subjected to an untargeted global lipidomic analysis. Lipids were extracted and subjected to Liquid Chromatography–Mass Spectrometry (LC-MS/MS). Annotated lipids were normalized and subjected to statistical analysis. Lipid clusters’ fold change (FC) and individual lipid features were compared at different time points. Lipids were also analyzed by structural composition and saturation bonding. Results: A total of 1057 H. contortus lipid features were annotated, including glycerophospholipids, fatty acyls, sphingolipids, glycerolipids, and sterols. Most of these compounds were unsaturated lipids. We found significant FC differences in the lipid profile in a time-dependent manner. Conclusions: We predict that many lipids found in our study act as signaling molecules for nematodes’ physiological functions, such as adaptation to nutrient changes, life span and mating, and as modulators on the host immune responses.
- Open Access
- 11 December 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (12) , 1717
Lipidomics Profiling of Metformin-Induced Changes in Obesity and Type 2 Diabetes Mellitus: Insights and Biomarker Potential
Metformin is the first-line oral medication for treating type 2 diabetes mellitus (T2DM). In the current study, an untargeted lipidomic analytical approach was used to investigate the alterations in the serum lipidome of a cohort of 89 participants, including healthy lean controls and obese diabetic patients, and to examine the alterations associated with metformin administration. A total of 115 lipid molecules were significantly dysregulated (64 up-regulated and 51 down-regulated) in the obese compared to lean controls. However, the levels of 224 lipid molecules were significantly dysregulated (125 up-regulated and 99 down-regulated) in obese diabetic patients compared to the obese group. Metformin administration in obese diabetic patients was associated with significant dysregulation of 54 lipid molecule levels (20 up-regulated and 34 down-regulated). Levels of six molecules belonging to five lipid subclasses were simultaneously dysregulated by the effects of obesity, T2DM, and metformin. These include two putatively annotated triacylglycerols (TGs), one plasmenyl phosphatidylcholine (PC), one phosphatidylglycerol (PGs), one sterol lipid (ST), and one Mannosyl-phosphoinositol ceramide (MIPC). This study provides new insights into our understanding of the lipidomics alterations associated with obesity, T2DM, and metformin and offers a new platform for potential biomarkers for the progression of diabetes and treatment response in obese patients.
- 11 December 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (12) , 1717
Open AccessLipidomics Profiling of Metformin-Induced Changes in Obesity and Type 2 Diabetes Mellitus: Insights and Biomarker Potential
Metformin is the first-line oral medication for treating type 2 diabetes mellitus (T2DM). In the current study, an untargeted lipidomic analytical approach was used to investigate the alterations in the serum lipidome of a cohort of 89 participants, including healthy lean controls and obese diabetic patients, and to examine the alterations associated with metformin administration. A total of 115 lipid molecules were significantly dysregulated (64 up-regulated and 51 down-regulated) in the obese compared to lean controls. However, the levels of 224 lipid molecules were significantly dysregulated (125 up-regulated and 99 down-regulated) in obese diabetic patients compared to the obese group. Metformin administration in obese diabetic patients was associated with significant dysregulation of 54 lipid molecule levels (20 up-regulated and 34 down-regulated). Levels of six molecules belonging to five lipid subclasses were simultaneously dysregulated by the effects of obesity, T2DM, and metformin. These include two putatively annotated triacylglycerols (TGs), one plasmenyl phosphatidylcholine (PC), one phosphatidylglycerol (PGs), one sterol lipid (ST), and one Mannosyl-phosphoinositol ceramide (MIPC). This study provides new insights into our understanding of the lipidomics alterations associated with obesity, T2DM, and metformin and offers a new platform for potential biomarkers for the progression of diabetes and treatment response in obese patients.
- Open Access
- 25 July 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (8) , 883
An Integrated Multi-OMICS Approach Highlights Elevated Non-Esterified Fatty Acids Impact BeWo Trophoblast Metabolism and Lipid Processing
Maternal obesity and gestational diabetes mellitus (GDM) are linked with impaired placental function and early onset of non-communicable cardiometabolic diseases in offspring. Previous studies have highlighted that the dietary non-esterified fatty acids (NEFAs) palmitate (PA) and oleate (OA), key dietary metabolites associated with maternal obesity and GDM, are potential modulators of placental lipid processing. Using the BeWo cell line model, the current study integrated transcriptomic (mRNA microarray), metabolomic, and lipidomic readouts to characterize the underlying impacts of exogenous PA and OA on placental villous trophoblast cell metabolism. Targeted gas chromatography and thin-layer chromatography highlighted that saturated and monounsaturated NEFAs differentially impact BeWo cell lipid profiles. Furthermore, cellular lipid profiles differed when exposed to single and multiple NEFA species. Additional multi-omic analyses suggested that PA exposure is associated with enrichment in β-oxidation pathways, while OA exposure is associated with enrichment in anti-inflammatory and antioxidant pathways. Overall, this study further demonstrated that dietary PA and OA are important regulators of placental lipid metabolism. Encouraging appropriate dietary advice and implementing dietary interventions to maintain appropriate placental function by limiting excessive exposure to saturated NEFAs remain crucial in managing at-risk obese and GDM pregnancies.
- 25 July 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (8) , 883
Open AccessAn Integrated Multi-OMICS Approach Highlights Elevated Non-Esterified Fatty Acids Impact BeWo Trophoblast Metabolism and Lipid Processing
Maternal obesity and gestational diabetes mellitus (GDM) are linked with impaired placental function and early onset of non-communicable cardiometabolic diseases in offspring. Previous studies have highlighted that the dietary non-esterified fatty acids (NEFAs) palmitate (PA) and oleate (OA), key dietary metabolites associated with maternal obesity and GDM, are potential modulators of placental lipid processing. Using the BeWo cell line model, the current study integrated transcriptomic (mRNA microarray), metabolomic, and lipidomic readouts to characterize the underlying impacts of exogenous PA and OA on placental villous trophoblast cell metabolism. Targeted gas chromatography and thin-layer chromatography highlighted that saturated and monounsaturated NEFAs differentially impact BeWo cell lipid profiles. Furthermore, cellular lipid profiles differed when exposed to single and multiple NEFA species. Additional multi-omic analyses suggested that PA exposure is associated with enrichment in β-oxidation pathways, while OA exposure is associated with enrichment in anti-inflammatory and antioxidant pathways. Overall, this study further demonstrated that dietary PA and OA are important regulators of placental lipid metabolism. Encouraging appropriate dietary advice and implementing dietary interventions to maintain appropriate placental function by limiting excessive exposure to saturated NEFAs remain crucial in managing at-risk obese and GDM pregnancies.
- Open Access
- 14 June 2023
- Published by MDPI AG in Preprints.org
An Integrated Multi-OMICS Approach Highlights Elevated Non-esterified Fatty Acids Impact BeWo Trophoblast Metabolism and Lipid Processing
Maternal obesity and gestational diabetes mellitus (GDM) are linked with impaired placental function and early onset of non-communicable cardiometabolic diseases in offspring. Previous studies have highlighted that the dietary non-esterified fatty acids (NEFAs), palmitate (PA) and oleate (OA), key dietary metabolites associated with maternal obesity and GDM, are potential modulators of placental lipid processing. Using the BeWo cell line model, the current study integrated transcriptomic (mRNA microarray), metabolomic, and lipidomic readouts to characterize the underlying impacts of exogenous PA and OA on placental villous trophoblast cell metabolism. Targeted gas chromatography and thin layer chromatography highlighted that saturated and monounsaturated NEFAs differentially impact BeWo cell lipid profiles. Furthermore, cellular lipid profiles differed when exposed to single and multiple NEFA species. Additional multi-omic analyses suggested that PA exposure is associated with enrichment in β-oxidation pathways, while OA exposure is associated with enrichment in anti-inflammatory and antioxidant pathways. Overall, this study further demonstrated that dietary PA and OA are important regulators of placental lipid metabolism. Encouraging appropriate dietary advise and implementing dietary interventions that maintain appropriate placental function by limiting excessive exposure to saturated NEFAs such as PA, will continue to be crucial in the clinical management of at-risk obese and GDM pregnancies.
- 14 June 2023
- Published by MDPI AG in Preprints.org
Open AccessAn Integrated Multi-OMICS Approach Highlights Elevated Non-esterified Fatty Acids Impact BeWo Trophoblast Metabolism and Lipid Processing
Maternal obesity and gestational diabetes mellitus (GDM) are linked with impaired placental function and early onset of non-communicable cardiometabolic diseases in offspring. Previous studies have highlighted that the dietary non-esterified fatty acids (NEFAs), palmitate (PA) and oleate (OA), key dietary metabolites associated with maternal obesity and GDM, are potential modulators of placental lipid processing. Using the BeWo cell line model, the current study integrated transcriptomic (mRNA microarray), metabolomic, and lipidomic readouts to characterize the underlying impacts of exogenous PA and OA on placental villous trophoblast cell metabolism. Targeted gas chromatography and thin layer chromatography highlighted that saturated and monounsaturated NEFAs differentially impact BeWo cell lipid profiles. Furthermore, cellular lipid profiles differed when exposed to single and multiple NEFA species. Additional multi-omic analyses suggested that PA exposure is associated with enrichment in β-oxidation pathways, while OA exposure is associated with enrichment in anti-inflammatory and antioxidant pathways. Overall, this study further demonstrated that dietary PA and OA are important regulators of placental lipid metabolism. Encouraging appropriate dietary advise and implementing dietary interventions that maintain appropriate placental function by limiting excessive exposure to saturated NEFAs such as PA, will continue to be crucial in the clinical management of at-risk obese and GDM pregnancies.